choice
Trump’s FDA Wants to Talk About Abortion Pills After the Election. Let’s Talk About Them Now.
No surprise, the Food and Drug Administration now plans to hold off on releasing its so-called safety review of mifepristone—the drug most often used in medication abortions—until March 2027, when the midterms will be safely in the rearview mirror.